Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy
SHANGHAI, Aug. 7, 2022 /PRNewswire/ -- Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for wide variety of diseases, today announced it has secured $20 million in Series Angel and Pre-A funding. Series Pre-A funding is jointly invested by...
WeTrade Group Announced a Strategic Partnership with Jiqing Bio Company, to Exclusively Sell Monkeypox Test Kits and Antigen Tests
BEIJING, Aug. 5, 2022 /PRNewswire/ -- On 5th August, WeTrade Group Inc. ("Wetrade" or the "Company") (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent systems for micro-businesses, today announced a strategic partnership with Jiqing Biomedical Technology Co. Ltd (Jiqing). The two companies plan to produce and provide exclusive sale channels...
United BioPharma’s Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms
New results demonstrate a newer class of anti-IgE antibody, UB-221, with superior neutralization, synthesis reduction, and durable relief in targeting allergic diseases TAIPEI, Aug. 5, 2022 /PRNewswire/ -- United BioPharma (UBP) today announced their latest results featuring unprecedented and unique functional characteristics of UB-221 monoclonal antibody in the phase I single-dose clinical trial, with chronic spontaneous urticaria (CSU)...
Yiling’s Lianhua Health Products Well-received: CICPE
SHIJIAZHUANG, China, Aug. 5, 2022 /PRNewswire/ -- As China's first national-level consumer expo and the largest such kind in the Asia-pacific region, the 2nd China International Consumer Products Expo (CICPE) attracted many audiences from different countries. And as the TOP 10 Chinese TCM Enterprise, Yiling Pharma (002603.SZ) presented its Lianhua health products on the expo. Yiling Pharma Booth ...
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 – Conference Call to Follow
SHANGHAI, Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2022, before the U.S. market opens on Thursday, August 25,...
FWD partners with Klook for customers in Southeast Asia
Accident Cover will be available through Klook in one seamless customer journey HONG KONG, Aug. 5, 2022 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "the Company") is delighted to announce a unique distribution partnership with Klook, a leading travel and leisure e-commerce platform for experiences and services, to launch a...
ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA
SINGAPORE, Aug. 5, 2022 /PRNewswire/ -- Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, named Gregory Lukasik senior vice president and market head for Southeast Asia. "Greg's experience with industrial businesses in Asia will help bring new perspectives and ideas to our strong Southeast Asia team and help...
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
Collaboration to accelerate the development and access of oncology medicines for cancer patients in China Clinical trial programs combining two of Sanofi's prioritized oncology assets with sintilimab, the leading checkpoint inhibitor in China, to address some of the most prevalent solid tumors in China Sanofi to make an initial equity investment of €300 million in Innovent in addition...
MGI Announces Commercial Availability of HotMPS Sequencing Chemistry*and Instrument**in the United Kingdom
SHENZHEN, China, July 28, 2022 /PRNewswire/ -- MGI Tech (MGI) announced that its innovative HotMPS sequencing chemistry* and instrument** are commercially available in the United Kingdom, from 23rd June 2022. Further details will be communicated during the 17th Annual Meeting of the International Conference of Genomics (ICG-17) in Riga. The sequencing chemistry HotMPS* was launched at the end...
Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector
Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology clinical trials market Genesis Capital is partnering with existing management to expand Crux into new testing and clinical trial streams MELBOURNE, Australia, Aug. 4, 2022 /PRNewswire/ -- Crux Biolabs, a leading Australian laboratory...
